A Study of the Gut Microbiome in Hormone Receptor-positive HER2-negative Breast Cancer Treated With CDK4/6 Inhibitors
Status: RECRUITING
Study type: OBSERVATIONAL
Conditions: Breast Cancer
Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Collaborators: Jules Bordet Institute